Wood ZA, Schrder E, Robin Harris J, Poole LB
Long-term success often becomes increasingly noticeable over several months of consistent treatment
In the search for answers and effective management strategies, functional medicine and clinical research have increasingly focused on mitochondrial health
in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody SEC.gov, accessed January 26, 2026, Ivonescimab (SMT112)* Akeso Partnership Summit Therapeutics Inc., accessed January 26, 2026, Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S
Oral betaine treatment for 7 days in a rat model of cholestasis-associated renal injury was found to decrease oxidative stress markers, improve mitochondrial indices, and alleviate histopathological changes in the kidney (Ommati et al., 2021)